Medicine & Health

The School of Medicine is joining a national research network aimed at diagnosing rare, previously undescribed diseases in patients whose conditions present as medical mysteries. The Undiagnosed Diseases Network is funded by the NIH and made up of 12 clinical sites and several research centers across the country.

Researchers at the School of Medicine have found that the same mutation that gives tuberculosis bacteria drug resistance also elicits a weaker immune response. The findings are published in Nature Microbiology.

The question of what constitutes “naturalness” — and consumers’ attitudes about it — lies at the heart of Washington University in St. Louis research from lead author Sydney Scott, assistant professor of marketing in the Olin Business School.

The signs of stress, anxiety or depression in a student may be easy to spot. The hard part is knowing what to do next. Kognito At-Risk for Faculty & Staff, an online simulation tool, will help Washington University in St. Louis faculty and staff lead effective discussions with struggling students.

A DNA-based analysis of blood cells soon after a stem cell transplant can predict likelihood of disease recurrence in patients with myelodysplastic syndrome (MDS), a group of cancerous disorders characterized by dysfunctional blood cells, according to new research at the School of Medicine.

The School of Medicine’s Jeffrey I. Gordon, MD, has received a 2018 Luminary Award from the Precision Medicine World Conference. He is being honored for his pioneering work in founding the field of gut microbiome research and for fundamentally altering the understanding of the origins of human health and disease, especially as they relate to nutrition.

Why don’t you eat your friend’s lunch when you are hungry? Cognitive control. Researchers at the School of Engineering & Applied Science and Arts & Sciences at Washington University in St. Louis are working together to better understand this aspect of cognition.

A new study from the School of Medicine shows that — in human tumor cells grown in the lab — a natural plant compound shuts down uveal melanoma cell growth.

A new study by the School of Medicine and others identifies mutations associated with relapse in ER positive breast cancer — knowledge that could lead to better therapies.

Hong Chen, assistant professor of biomedical engineering in the School of Engineering & Applied Science and assistant professor of radiation oncology at the School of Medicine, reached across disciplines to work toward a more focused drug delivery system that could target tumors lodged in the brainstem, the body’s most precious system.